Press What’s news at AbelsonTaylor Group
Select category
Leveraging Multi-Touch Attribution for Greater Brand Marketing Success
Even in the present age of AI, big data and omnichannel marketing, pharma brands—for the most part—are stuck to the traditional idea that the last touch, the last communication someone receives before converting, should get all, or most of the credit for that conversion. Or, they might not even know which touchpoints to attribute credit.
In her article in Muse by Clio, Rebecca Visconti, VP of Marketing Intelligence, looks beyond that conventional worship of the last touch to provide evidence-based methods to calculate the real impact of every touchpoint more accurately.
Read the full article at Muse by Clio
Media Contact:
Recent Posts
The AI-era interview: What healthcare agencies are really hiring for
AI may be changing how candidates apply and how agencies recruit, but the most valuable skills in healthcare marketing remain...
In the News Read more The AI-era interview: What healthcare agencies are really hiring forAmy Restko Promoted to Vice President, Engagement Strategy at AbelsonTaylor Group
AbelsonTaylor Group today announced the promotion of Amy Restko to Vice President, Engagement Strategy. A strategic leader with expertise in...
Read Press Read more Amy Restko Promoted to Vice President, Engagement Strategy at AbelsonTaylor GroupCybersecurity considerations in pharma marketing: Trust must come first
“Responsible AI adoption is essential to protecting our clients, our agency, and the patients ultimately served by the work we...
In the News Read more Cybersecurity considerations in pharma marketing: Trust must come firstConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.